JP2002509889A5 - - Google Patents

Download PDF

Info

Publication number
JP2002509889A5
JP2002509889A5 JP2000540834A JP2000540834A JP2002509889A5 JP 2002509889 A5 JP2002509889 A5 JP 2002509889A5 JP 2000540834 A JP2000540834 A JP 2000540834A JP 2000540834 A JP2000540834 A JP 2000540834A JP 2002509889 A5 JP2002509889 A5 JP 2002509889A5
Authority
JP
Japan
Prior art keywords
cmt
dimethylamino
tetracycline
inhibitor
stated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2000540834A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002509889A (ja
Filing date
Publication date
Priority claimed from US09/052,222 external-priority patent/US6277061B1/en
Application filed filed Critical
Publication of JP2002509889A publication Critical patent/JP2002509889A/ja
Publication of JP2002509889A5 publication Critical patent/JP2002509889A5/ja
Abandoned legal-status Critical Current

Links

JP2000540834A 1998-03-31 1999-03-30 膜型マトリックスメタロプロテイナーゼを阻害する方法 Abandoned JP2002509889A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/052,222 1998-03-31
US09/052,222 US6277061B1 (en) 1998-03-31 1998-03-31 Method of inhibiting membrane-type matrix metalloproteinase
PCT/US1999/006972 WO1999049871A1 (en) 1998-03-31 1999-03-30 Method of inhibiting membrane-type matrix metalloproteinase

Publications (2)

Publication Number Publication Date
JP2002509889A JP2002509889A (ja) 2002-04-02
JP2002509889A5 true JP2002509889A5 (cg-RX-API-DMAC7.html) 2006-06-01

Family

ID=21976191

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000540834A Abandoned JP2002509889A (ja) 1998-03-31 1999-03-30 膜型マトリックスメタロプロテイナーゼを阻害する方法

Country Status (8)

Country Link
US (2) US6277061B1 (cg-RX-API-DMAC7.html)
EP (1) EP1079837A4 (cg-RX-API-DMAC7.html)
JP (1) JP2002509889A (cg-RX-API-DMAC7.html)
KR (1) KR20010042322A (cg-RX-API-DMAC7.html)
AU (1) AU748870B2 (cg-RX-API-DMAC7.html)
CA (1) CA2320260A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ506153A (cg-RX-API-DMAC7.html)
WO (1) WO1999049871A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
EP1174129A1 (en) * 2000-07-17 2002-01-23 Zenner, Hans Peter, Prof. Dr. med. Use of a matrix-metalloprotease inhibitor for the treatment of cancer
EP1408987B1 (en) 2001-07-13 2013-04-10 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
WO2003030819A2 (en) * 2001-10-05 2003-04-17 Tetragenex Pharmaceuticals, Inc. Tetracycline derivatives and methods of use thereof
CN100391464C (zh) * 2001-12-03 2008-06-04 诺瓦西股份有限公司 含活性维生素d化合物的药物组合物
WO2003053447A1 (en) * 2001-12-20 2003-07-03 Hanauske-Abel Hartmut M Treatment for averting or delaying premature delivery
EP2311797A1 (en) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
JP2005526754A (ja) 2002-03-08 2005-09-08 パラテック ファーマシューティカルズ インコーポレイテッド アミノメチル置換されたテトラサイクリン化合物
EP1503981A4 (en) 2002-03-21 2007-08-15 Paratek Pharm Innc SUBSTITUTED TETRACYCLINE COMPOUNDS
WO2003082011A1 (en) * 2002-03-29 2003-10-09 The Research Foundation Of State University Of New York Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
WO2004006850A2 (en) 2002-07-12 2004-01-22 Paratek Pharmaceuticals, Inc 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
US20040170621A1 (en) * 2002-08-30 2004-09-02 Roodman G. David Method of resisting osteoclast formation
US20040138162A1 (en) * 2002-08-30 2004-07-15 Roodman G. David Method of resisting osteoclast formation
JP4686189B2 (ja) 2002-10-24 2011-05-18 パラテック ファーマシューティカルズ インコーポレイテッド Rnaを調節するための置換テトラサイクリン化合物の使用方法
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2005009943A2 (en) 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド 9−アミノメチルテトラサイクリン化合物のプロドラッグ
EP2332904A3 (en) * 2004-01-15 2012-04-11 Paratek Pharmaceuticals, Inc. Derivatives of tetracycline compounds
JP2008518025A (ja) 2004-10-25 2008-05-29 パラテック ファーマシューティカルズ インコーポレイテッド 4−アミノテトラサイクリンおよびその使用の方法
WO2006047756A2 (en) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
CA2616224A1 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
US20070142337A1 (en) * 2005-12-15 2007-06-21 The Regents Of The University Of California Treatment of inflammation and organ dysfunction
PL2120963T3 (pl) 2006-12-21 2019-05-31 Paratek Pharm Innc Podstawione związki tetracyklinowe do leczenia zaburzeń zapalnych skóry
IL270446B2 (en) * 2006-12-21 2023-10-01 Paratek Pharm Innc A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition
EP2144870A2 (en) * 2007-04-27 2010-01-20 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
WO2009009042A1 (en) * 2007-07-06 2009-01-15 Paratek Pharmaceuticals, Inc. Methods for synthesizing substituted tetracycline compounds
TWI585071B (zh) 2008-05-19 2017-06-01 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
HUE026562T2 (hu) 2008-08-08 2016-06-28 Tetraphase Pharmaceuticals Inc C7-fluor-helyettesített tetraciklin vegyületek
CN102459153A (zh) 2009-05-08 2012-05-16 四相制药公司 四环素类化合物
EP2470500B1 (en) 2009-08-28 2017-10-04 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
WO2011123536A1 (en) 2010-03-31 2011-10-06 Tetraphase Pharmaceuticals, Inc. Polycyclic tetracycline compounds
LT2707003T (lt) 2011-05-12 2019-10-10 Paratek Pharmaceuticals, Inc. Kristalinės (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksirūgšties amido druskos ir jų panaudojimo būdai
TR201902057T4 (tr) 2012-08-31 2019-03-21 Tetraphase Pharmaceuticals Inc Tetrasiklin bileşikleri.
MA46567A (fr) 2016-10-19 2019-08-28 Tetraphase Pharmaceuticals Inc Formes cristallines de l'éravacycline
WO2020097450A1 (en) 2018-11-09 2020-05-14 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a compound and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
AU1411992A (en) 1991-01-15 1992-08-27 Robert A Bok A composition containing a tetracycline and use for inhibiting angiogenesis
JPH06256280A (ja) * 1992-11-17 1994-09-13 Univ New York State 糖尿病における過度のコラーゲン架橋結合を阻害する非抗菌性化学修飾テトラサイクリンを含むテトラサイクリン
US5668122A (en) * 1993-07-28 1997-09-16 Fife; Rose S. Method to treat cancer with tetracyclines
GB9615976D0 (en) 1996-07-30 1996-09-11 Center For Clinical & Basic Re The use of proteinase inhibitors for the prevention or reduction of bone resorption
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5837696A (en) 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth

Similar Documents

Publication Publication Date Title
WO1999049871A8 (en) Method of inhibiting membrane-type matrix metalloproteinase
CA2264552C (en) Method of using tetracycline compounds for inhibition of nitric oxide production
IT1289160B1 (it) Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
CA2339667A1 (en) Method of using tetracycline compounds to enhance interleukin-10 production
WO2003005971A3 (en) Tetracycline compounds having target therapeutic activities
CA2260337A1 (en) Therapeutic agents
AU4373993A (en) Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors
AU2002254036A1 (en) Taste masked pharmaceutical compositions
AU7031500A (en) Therapeutic quinazoline compounds
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
EP1002556A3 (en) Use of MMP inhibitors
IL148129A0 (en) System of reusable software parts for implementing concurrency and hardware access, and methods of use
AU2001241078A1 (en) Alpha-amylase activity inhibitors
EP1495754A3 (en) Method and composition for treating cancers
HUP0105302A2 (hu) 2,3,4,5-Tetrahidro-1H-[1,4]benzodiazepin-3-hidroxámsavak mint mátrix metalloproteináz-inhibitorok, alkalmazásuk és eljárás az előállításukra
BR9305783A (pt) Processo para preparar grânulos dispersiveis em água e grânulos dispersíveis em água
AU3111700A (en) Methods and compositions for treating inflammatory diseases utilizing inhibitorsof tumor necrosis factor activity
HUP0001294A3 (en) Heterocycleketo hydrazide derivatives having protease inhibitor activity, process for their preparation and their use
IL139566A0 (en) Factors affecting tumor necrosis factor releasing enzyme activity
AU4888401A (en) Sulfonamide derivative as a matrix metalloproteinase inhibitor
ZA964818B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
AU7671198A (en) Methods for the inhibition of neuronal activity by local delivery of adenosi ne
AU8742198A (en) Use of cholinesterase inhibitor for treating diseases associated with pro teolytic enzyme activity
NO964472L (no) Halogenmetylamider som IL-1-prosteaseinhibirorer
BR9607384A (pt) Válvula para elevador hidráulico